Literature DB >> 32796958

LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression.

Yuxing Zhu1, Jingjing Li1,2, Hao Bo3,4, Dong He5, Mengqing Xiao1, Liang Xiang1, Lian Gong1, Yi Hu1, Yeyu Zhang1, Yaxin Cheng1, Liping Deng1, Rongrong Zhu1, Yanni Ma1, Ke Cao6.   

Abstract

The long non-coding RNA (LncRNA) abnormally expresses in several cancers including non-small cell lung cancer (NSCLC). To better understand the role of key lncRNA involving cancer progress, we conduct a comprehensive data mining on LINC00467 and determine its molecular mechanisms. We identified LINC00467 was the up-regulated lncRNA that common significantly differentially expressed in NSCLC and CRC tissues from GEO database. LINC00467 highly expressed in NSCLC tissues and associated with advanced clinical stages and poor outcome. Knockdown of LINC00467 inhibited cell growth and metastasis via regulating the Akt signaling pathway. Finally, we demonstrated that TDG mediated acetylation is the key factor controlling LINC00467 expression. In conclusion, LINC00467 promotes NSCLC progression via Akt signal pathway. The identified LINC00467 may serve as a valuable diagnostic and prognostic biomarker as well as a therapeutic target for NSCLC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32796958     DOI: 10.1038/s41388-020-01421-w

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  LncRNA TUG1 regulates FGF1 to enhance endothelial differentiation of adipose-derived stem cells by sponging miR-143.

Authors:  Ya-Nan Xue; Yu Yan; Zi-Zi Chen; Jia Chen; Feng-Jie Tang; Hui-Qing Xie; Shi-Jie Tang; Ke Cao; Xiao Zhou; Ai-Jun Wang; Jian-Da Zhou
Journal:  J Cell Biochem       Date:  2019-07-01       Impact factor: 4.429

Review 2.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

3.  Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer.

Authors:  Naiyer A Rizvi; Solange Peters
Journal:  N Engl J Med       Date:  2017-11-16       Impact factor: 91.245

Review 4.  New and emerging targeted treatments in advanced non-small-cell lung cancer.

Authors:  Fred R Hirsch; Kenichi Suda; Jacinta Wiens; Paul A Bunn
Journal:  Lancet       Date:  2016-09-01       Impact factor: 79.321

5.  The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.

Authors:  Yuxing Zhu; Dong He; Hao Bo; Zexian Liu; Mengqing Xiao; Liang Xiang; Jianda Zhou; Yan Liu; Xiaoming Liu; Lian Gong; Yanni Ma; Yanhong Zhou; Ming Zhou; Wei Xiong; Fei Yang; Xiaowei Xing; Ruhong Li; Wei Li; Ke Cao
Journal:  Oncogene       Date:  2019-07-04       Impact factor: 9.867

6.  Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.

Authors:  Junjie Tony Hua; Musaddeque Ahmed; Haiyang Guo; Yuzhe Zhang; Sujun Chen; Fraser Soares; Jennifer Lu; Stanley Zhou; Miranda Wang; Hui Li; Nicholas B Larson; Shannon K McDonnell; Parasvi S Patel; Yi Liang; Cindy Q Yao; Theodorus van der Kwast; Mathieu Lupien; Felix Y Feng; Amina Zoubeidi; Ming-Sound Tsao; Stephen N Thibodeau; Paul C Boutros; Housheng Hansen He
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

7.  A continuous fermentation technique for studying the kinetics of sugar uptake by baker's yeast.

Authors:  W E Trevelyan
Journal:  Biochem J       Date:  1966-08       Impact factor: 3.857

8.  LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.

Authors:  Shuquan Wei; Kangwei Wang; Xiaomei Huang; Zhuxiang Zhao; Ziwen Zhao
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

Review 9.  Functions of lncRNA HOTAIR in lung cancer.

Authors:  Gregory Loewen; Janarthanan Jayawickramarajah; Ying Zhuo; Bin Shan
Journal:  J Hematol Oncol       Date:  2014-12-10       Impact factor: 17.388

10.  Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer.

Authors:  Alejandro Herreros-Pomares; Juan Diego de-Maya-Girones; Silvia Calabuig-Fariñas; Rut Lucas; Alicia Martínez; José Miguel Pardo-Sánchez; Sergio Alonso; Ana Blasco; Ricardo Guijarro; Miguel Martorell; Eva Escorihuela; María Dolores Chiara; Elena Duréndez; Carolina Gandía; Jerónimo Forteza; Rafael Sirera; Eloísa Jantus-Lewintre; Rosa Farràs; Carlos Camps
Journal:  Cell Death Dis       Date:  2019-09-10       Impact factor: 8.469

View more
  16 in total

Review 1.  The base excision repair process: comparison between higher and lower eukaryotes.

Authors:  Nagham Nafiz Hindi; Noha Elsakrmy; Dindial Ramotar
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

2.  Micropeptide ASAP encoded by LINC00467 promotes colorectal cancer progression by directly modulating ATP synthase activity.

Authors:  Qiwei Ge; Dingjiacheng Jia; Dong Cen; Yadong Qi; Chengyu Shi; Junhong Li; Lingjie Sang; Luo-Jia Yang; Jiamin He; Aifu Lin; Shujie Chen; Liangjing Wang
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

3.  Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis.

Authors:  Xianjuan Shen; Shan Kong; Shuo Ma; Lei Shen; Ming Zheng; Shiyi Qin; Jing Qi; Qiuhong Wang; Xiaopeng Cui; Shaoqing Ju
Journal:  Oncogene       Date:  2022-09-15       Impact factor: 8.756

4.  LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway.

Authors:  Jianqun Ma; Kui Cao; Xiaodong Ling; Ping Zhang; Jinhong Zhu
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

5.  LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.

Authors:  Wen Wang; Hao Bo; Yumei Liang; Guoli Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-13       Impact factor: 5.555

6.  Long noncoding RNA NR2F1-AS1 stimulates the tumorigenic behavior of non-small cell lung cancer cells by sponging miR-363-3p to increase SOX4.

Authors:  Luming Jin; Chaoyang Chen; Lipeng Huang; Qingyu Sun; Liang Bu
Journal:  Open Med (Wars)       Date:  2021-12-16

7.  N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer.

Authors:  Xin Nie; Jichun Tan
Journal:  Hereditas       Date:  2022-03-18       Impact factor: 3.271

8.  LINC00467 Promotes Prostate Cancer Progression via M2 Macrophage Polarization and the miR-494-3p/STAT3 Axis.

Authors:  Hao Jiang; Wen Deng; Ke Zhu; Zhenhao Zeng; Bing Hu; Zhengtao Zhou; An Xie; Cheng Zhang; Bin Fu; Xiaochen Zhou; Gongxian Wang
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

9.  LINC00467 Promotes Tumor Progression via Regulation of the NF-kb Signal Axis in Bladder Cancer.

Authors:  Jiawei Xiao; Lian Gong; Mengqing Xiao; Dong He; Liang Xiang; Zhanwang Wang; Yaxin Cheng; Liping Deng; Ke Cao
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

10.  LINC00467, Driven by Copy Number Amplification and DNA Demethylation, Is Associated with Oxidative Lipid Metabolism and Immune Infiltration in Breast Cancer.

Authors:  Hao Bo; Wancong Zhang; Xiaoping Zhong; Jiasheng Chen; Yang Liu; Kit-Leong Cheong; Pengju Fan; Shijie Tang
Journal:  Oxid Med Cell Longev       Date:  2021-12-15       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.